iMeducation101

iMeducation101 - Education for physicians and #BasicPhysicianTrainees ... Neurological Examination Videos 👇🏼👇🏼👇🏼

[iMeducation101 @meducation101]

Neurological Examination of the Lower Limb https://t.co/kGtWB9Ak6d via @YouTube #medicaleducation #medicine #neurology #clinicalexam #BPT #MedStudentTwitter

Let us know what you think 🤔

[Dr Benjamin P Trewin @Benjamin_Trewin]

I am very pleased that research groups have read and cited my papers over 1,000 times!!!

Hopefully there will be thousands more as we continue to unlock the mysteries of #Neuroimmunology =)

#MOGAD #MultipleSclerosis #NMOSD

https://t.co/lZtM5RKzjs

[Dr Benjamin P Trewin @Benjamin_Trewin]

Maintenance Immunotherapy in #MOGAD #NeurologyMinute @AANmember

https://t.co/Pg0KFoDTxP

🎙️There is strong evidence that ≥12.5 mg/day (0.16 mg/kg/day paediatric) corticosteroids for 5 months from MOGAD onset reduces risk of relapse and permanent disability📉

#Neuroimmunology

[Dr Benjamin P Trewin @Benjamin_Trewin]

Nothing sharpens your own thinking quite like a room full of neurologists poking at it. Packed house, incisive questions, proper debate. Plenty to take home and consider. Thank you 🙏 #AANAM 2026 #MOGAD

[Dr Benjamin P Trewin @Benjamin_Trewin]

“Perfect is the enemy of good”
- Voltaire (and Dr Thabele Leslie-Mazwi)
What a great start to this year’s #AANAM

[Neurochecklists @neurochecklists]

MOGAD: A comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globally
https://t.co/lNTwZ1B7LP

[Dr Benjamin P Trewin @Benjamin_Trewin]

Thrilled to share our group’s work on maintenance immunotherapy in #MOGAD has been accepted for oral presentation at the American Academy of Neurology Annual Meeting in Chicago this April.

Window of early steroid benefit, dose thresholds & disability risk. 🧠

#AANAM @AANmember

[Dr Benjamin P Trewin @Benjamin_Trewin]

The thesis has landed! 🚀📚🎓 After years of rewrites, stats, and soul-searching, it’s finally real!

Huge thanks to @darshi_r and co-supervisors @RussellCDale, @FabienneBrilot & the MOG-dawggz! 🤘

#PhD #Neuroimmunology #MOGAD #AcademicTwitter @Sydney_Uni @DBworm @TheMOGProject

[Dr Benjamin P Trewin @Benjamin_Trewin]

https://t.co/D1MVhTUsIa
https://t.co/vmpjHRvuJO

[Dr Benjamin P Trewin @Benjamin_Trewin]

Great to be a part of this, well done @MasturaMonif and Jessica Shipley. Thank you for getting this important work for our patients together - a mammoth effort! 👏
#MultipleSclerosis

[Alvaro Cobo Calvo @cobo_calvo]

Happy to share our international (🇪🇸🇫🇷🇮🇹🇨🇭) collaborative study focused on the role of cytokines measured by ELLA system in MOGAD.
https://t.co/FaWwhJSBUd

[Dr Benjamin P Trewin @Benjamin_Trewin]

https://t.co/fH8lRl7uZy

[Sudarshini Ramanathan @darshi_r]

Check out our definitive review of 4699 international MOGAD patients - @Benjamin_Trewin highlights the relapsing propensity, novel radiological comparisons between children and adults, prognostic biomarkers, and therapeutic practices globally - a review not to miss #MOGAD

[Dr Benjamin P Trewin @Benjamin_Trewin]

MOGAD: A comprehensive review of clinicoradiological features, therapy and outcomes in 4,699 patients globally

https://t.co/asBsIDTvJw

🧵Just published in Autoimmunity Reviews 🗞️: Our systematic review across 31 countries challenges fundamental assumptions about MOGAD! ⬇️👇

[Dr Benjamin P Trewin @Benjamin_Trewin]

🚨Excited to announce the publication of our latest case report! A patient with an incredible 52-year time to first relapse challenges the traditional monophasic vs relapsing dichotomy in #MOGAD💡
Relapsing propensity is a spectrum🌈
🙏Todd Hardy @darshi_r
https://t.co/ubaxvCuHe4

[Sudarshini Ramanathan @darshi_r]

⁦Fantastic presentation from ⁦@Benjamin_Trewin⁩ regarding his data on optimal therapeutic dosing of corticosteroids at #MOGAD onset delaying time to first relapse @ECTRIMS. Great audience discussions ⁦@syd_health⁩ ⁦@kids_research⁩ ⁦⁦⁦

[Dr Benjamin P Trewin @Benjamin_Trewin]

🌟 Honoured to present at the NOSA/NOTSA 2024 conference on the treatment of MOGAD! Thank you to the organizers for the opportunity. Excited to share insights and connect with fellow professionals! 🙌 #NOSA2024 #MOGAD #Neurology #Ophthalmology 📸✨

[Dr Benjamin P Trewin @Benjamin_Trewin]

Looking forward to my platform presentation at #ECTRIMS2024! We'll be diving deep into our findings on the utility of #corticosteroids at #MOGAD onset. Get ready to engage and learn together 🎓🔍💡!
#MS #Neuroimmunology #Copenhagen 🇩🇰 https://t.co/enW26oVHh3

[NeurologyLive® @neurology_live]

Data from a recently published study showed that daily prednisone at doses of 12.5 mg daily for a minimum of 3 months at the onset of #MOGAD delays time to first relapse.

https://t.co/ireyTQjCgj

[Dr Benjamin P Trewin @Benjamin_Trewin]

Higher Doses of Oral Prednisone Delays Relapse Onset in MOG-Antibody Disease https://t.co/6yWu3hTU9q via @neurology_live

[Dr Benjamin P Trewin @Benjamin_Trewin]

Stoked to have presented my #systematicreview of 4,812 people worldwide with #MOGAD at #ANZAN this afternoon. Thank you for the opportunity and thank you @darshi_r for your tireless guidance!